279 related articles for article (PubMed ID: 25786223)
1. Short-term treatment with diminazene aceturate ameliorates the reduction in kidney ACE2 activity in rats with subtotal nephrectomy.
Velkoska E; Patel SK; Griggs K; Pickering RJ; Tikellis C; Burrell LM
PLoS One; 2015; 10(3):e0118758. PubMed ID: 25786223
[TBL] [Abstract][Full Text] [Related]
2. Diminazene Aceturate Improves Cardiac Fibrosis and Diastolic Dysfunction in Rats with Kidney Disease.
Velkoska E; Patel SK; Griggs K; Burrell LM
PLoS One; 2016; 11(8):e0161760. PubMed ID: 27571511
[TBL] [Abstract][Full Text] [Related]
3. Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition.
Burrell LM; Burchill L; Dean RG; Griggs K; Patel SK; Velkoska E
Exp Physiol; 2012 Apr; 97(4):477-85. PubMed ID: 22198016
[TBL] [Abstract][Full Text] [Related]
4. Reduction in renal ACE2 expression in subtotal nephrectomy in rats is ameliorated with ACE inhibition.
Velkoska E; Dean RG; Burchill L; Levidiotis V; Burrell LM
Clin Sci (Lond); 2010 Feb; 118(4):269-79. PubMed ID: 19698082
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice.
Qiu Y; Shil PK; Zhu P; Yang H; Verma A; Lei B; Li Q
Invest Ophthalmol Vis Sci; 2014 May; 55(6):3809-18. PubMed ID: 24854854
[TBL] [Abstract][Full Text] [Related]
6. Is the cardioprotective effect of the ACE2 activator diminazene aceturate more potent than the ACE inhibitor enalapril on acute myocardial infarction in rats?
Badae NM; El Naggar AS; El Sayed SM
Can J Physiol Pharmacol; 2019 Jul; 97(7):638-646. PubMed ID: 30840489
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme 2 activator diminazene aceturate prevents lipopolysaccharide-induced inflammation by inhibiting MAPK and NF-κB pathways in human retinal pigment epithelium.
Tao L; Qiu Y; Fu X; Lin R; Lei C; Wang J; Lei B
J Neuroinflammation; 2016 Feb; 13():35. PubMed ID: 26862037
[TBL] [Abstract][Full Text] [Related]
8. Beneficial Effects of the Angiotensin-Converting Enzyme 2 Activator Dize in Renovascular Hypertension.
Kangussu LM; de Almeida TCS; Prestes TRR; de Andrade De Maria ML; da Silva Filha R; Vieira MAR; Silva ACSE; Ferreira AJ
Protein Pept Lett; 2019; 26(7):523-531. PubMed ID: 30950337
[TBL] [Abstract][Full Text] [Related]
9. Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology.
Qi Y; Zhang J; Cole-Jeffrey CT; Shenoy V; Espejo A; Hanna M; Song C; Pepine CJ; Katovich MJ; Raizada MK
Hypertension; 2013 Oct; 62(4):746-52. PubMed ID: 23959549
[TBL] [Abstract][Full Text] [Related]
10. ACE2 activator diminazene aceturate reduces adiposity but preserves lean mass in young and old rats.
Bruce EB; Sakarya Y; Kirichenko N; Toklu HZ; Sumners C; Morgan D; Tümer N; Scarpace PJ; Carter CS
Exp Gerontol; 2018 Oct; 111():133-140. PubMed ID: 30006298
[TBL] [Abstract][Full Text] [Related]
11. Diminazene aceturate extenuate the renal deleterious consequences of angiotensin-II induced by γ-irradiation through boosting ACE2 signaling cascade.
Hasan HF; Elgazzar EM; Mostafa DM
Life Sci; 2020 Jul; 253():117749. PubMed ID: 32380079
[TBL] [Abstract][Full Text] [Related]
12. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
[TBL] [Abstract][Full Text] [Related]
13. Diminazene aceturate prevents nephropathy by increasing glomerular ACE2 and AT
Goru SK; Kadakol A; Malek V; Pandey A; Sharma N; Gaikwad AB
Br J Pharmacol; 2017 Sep; 174(18):3118-3130. PubMed ID: 28688122
[TBL] [Abstract][Full Text] [Related]
14. Activation of angiotensin-converting enzyme 2 (ACE2) attenuates allergic airway inflammation in rat asthma model.
Dhawale VS; Amara VR; Karpe PA; Malek V; Patel D; Tikoo K
Toxicol Appl Pharmacol; 2016 Sep; 306():17-26. PubMed ID: 27343405
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin converting enzyme 2 and diminazene: role in cardiovascular and blood pressure regulation.
Velkoska E; Patel SK; Burrell LM
Curr Opin Nephrol Hypertens; 2016 Sep; 25(5):384-95. PubMed ID: 27367913
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective effects of diminazene aceturate in pressure-overloaded rat hearts.
Macedo LM; Souza ÁP; De Maria ML; Borges CL; Soares CM; Pedrino GR; Colugnati DB; Santos RA; Mendes EP; Ferreira AJ; Castro CH
Life Sci; 2016 Jun; 155():63-9. PubMed ID: 27153779
[TBL] [Abstract][Full Text] [Related]
17. Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression.
Burchill L; Velkoska E; Dean RG; Lew RA; Smith AI; Levidiotis V; Burrell LM
Exp Physiol; 2008 May; 93(5):622-30. PubMed ID: 18223026
[TBL] [Abstract][Full Text] [Related]
18. Diminazene protects corpus cavernosum against hypercholesterolemia-induced injury.
Fraga-Silva RA; Costa-Fraga FP; Montecucco F; Sturny M; Faye Y; Mach F; Pelli G; Shenoy V; da Silva RF; Raizada MK; Santos RA; Stergiopulos N
J Sex Med; 2015 Feb; 12(2):289-302. PubMed ID: 25411084
[TBL] [Abstract][Full Text] [Related]
19. Adverse cardiac effects of exogenous angiotensin 1-7 in rats with subtotal nephrectomy are prevented by ACE inhibition.
Burrell LM; Gayed D; Griggs K; Patel SK; Velkoska E
PLoS One; 2017; 12(2):e0171975. PubMed ID: 28192475
[TBL] [Abstract][Full Text] [Related]
20. [ACE2 agonist DIZE alleviates lung injury induced by limb ischemia-reperfusion in mice].
Li SM; Wang XY; Liu F; Yang XH
Sheng Li Xue Bao; 2018 Apr; 70(2):175-183. PubMed ID: 29691582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
